Development and in vitro evaluation of expandable gastroretentive dosage forms based on compressed collagen sponges

Pharmazie

Volumn 61, Issue 7, 2006, Pages 608-612

  Groning R ^a   Cloer, C ^a   Muller R S ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CAPTOPRIL; COLLAGEN; HYDROXYPROPYLMETHYLCELLULOSE; RIBOFLAVIN;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG MANUFACTURE; DRUG RELEASE; DRUG SCREENING; FREEZE DRYING; HYDROPHILICITY; IN VITRO STUDY; STOMACH JUICE; TABLET COMPRESSION;

ACYCLOVIR; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIVIRAL AGENTS; CAPTOPRIL; CATTLE; COLLAGEN; DOSAGE FORMS; FREEZE DRYING; HEAT; HYDROCHLORIC ACID; MALE; NECK; PROTEIN DENATURATION; RIBOFLAVIN; SKIN; STOMACH; TABLETS; VITAMINS;

EID: 33746253250     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Abrahamsson B, Alpsten M, Jonsson UE, Lundberg PJ, Sandberg A, Sundgren M, Svenheden A, Tolli J (1996) Gastro-intestinal transit of a multiple-unit formulation (metoprolol CR/ZOK) and a non-disintegrating tablet with the emphasis on colon. Int J Pharm 140: 229-235.
2. Akiyama Y, Nagahara N, Nara E, Kitano M, Iwasa S, Yamamoto I, Azuma J, Ogawa Y (1998) Evaluation of oral mucoadhesive microspheres in man on the basis of the pharmacokinetics of furosemide and riboflavin, compounds with limited gastrointestinal absorption sites. J Pharm Pharmacol 50: 159-166.
3. Brown BP, Schulze-Delrieu K, Schrier JE, Abu-Jousef MM (1993) The configuration of the human gastroduodenal junction in the separate emptying of liquids and solids. Gastroenterology 105: 433-440.
4. Chen J, Blevins WE, Park H, Park K (2000) Gastric retention properties of superporous hydrogel composites. J Control Rel 64: 39-51.
5. Cloer C (1999) Entwicklung expandierender Magenverweilarzneiformen auf Kollagenbasis. Schriftenreihe Institut für Pharmazeutische Technologie, 1, Münster.
6. Collard JM, Romagnoli R (2001) Human stomach has a recordable mechanical activity at a rate of about three cycles/minute. Acta chirurgica 167: 188-194.
7. Coupe AJ, Davis SS, Evans DF, Wilding IR (1991) Correlation of the gastric emptying of nondisintegratig tablets with gastrointestinal motility. Pharm Res 8: 1281-1285.
8. Demol P, Singer MV, Hotz J, Dipp M, Goebell H (1984) Interdigestive gastrointestinal motility and secretion of gastric acid and pancreatic enzymes in young cigaret smokers. Digestion 29: 107-111.
9. Deshpande AA, Shah NH, Rhodes CT, Malick W (1997) Development of a novel controlled-release system for gastric retention. Pharm Res 14: 815-819.
10. Eckmayer (1983) Verfahren zur Herstellung von feinporigen Kollagenschwämmen. Offenlegungsschrift DE 3203957A1.
11. Friess W (1998) Collagen - biomaterial for drug delivery. Eur J Pharm Biopharm 45: 113-136.
12. Gröning R (1981) Control of release and biological availability of drugs - investigations into the renal elimination of nitrofurantoin. Int J Pharm 8: 175-181.
13. Gröning R (1984) Gastrointestinal passage and bioavailability of peroral drug forms. Pharm Ind 46: 88-96.
14. Gröning R, Berntgen M, Geogorakis M (1998) Acyclovir serum concentrations following peroral administration of magnetic depot tablets and the influence of extracorporal magnets to control gastrointestinal transit. Eur J Pharm Biopharm 46: 285-291.
15. Gröning R, Heun G (1989) Dosage forms with controlled gastrointestinal passage -studies on the absorption of nitrofurantoin. Int J Pharm 56: 111-116.
16. Gupta PK, Robinson JR (1995) Effect of volume and viscosity of coadministered fluid on gastrointestinal distribution of small particles. Int J Pharm 125: 185-193.
17. Hu M, Amidon GL (1988) Passive and carrier-mediated intestinal absorption components of captopril. J Pharm Sci 77: 1007-1011.
18. Ireson JD, Leslie GB (1971) In vitro investigation of bulk-forming appetite-suppressants. Pharm J 207: 65.
19. Jusko W, Levy G (1967) Absorption, metabolism, and excretion of riboflavin-5′-phosphat in man. J Pharm Sci 56: 58-62.
20. Klausner EA, Lavy E, Friedman M, Hoffman A (2003) Expandable gastroretentive dosage forms. J Control Release 90: 143-162.
21. Klausner EA, Lavy E, Stepensky D, Friedman M, Hoffman A (2002) Novel gastroretentive dosage forms: evaluation of gastroretentivity and its effect on riboflavin absorption in dogs. Pharm Res 19: 1516-1523.
22. Lee L, Hossain M, Wang Y, Sedek G (2004) Absorption of rivastigmine from different regions of the gastrointestinal tract in humans. J Clin Pharmacol 44: 599-604.
23. Levy G, Gilbaldi M (1972) Effect of an anticholinergic agent on riboflavin absorption in man. J Pharm Sci 61: 798-799.
24. Levy G, Jusko W (1966) Factors affecting the absorption of riboflavin in man. J Pharm Sci 55: 285-289.
25. Levy G, Rao KP (1972) Enhanced intestinal absorption of riboflavin from sodium alginate solution in man. J Pharm Sci 61: 279-280.
26. Lewis LD, Fowle ASE, Bittiner SB, Bye A, Isaacs PET (1986) Human gastrointestinal absorption of acyclovir from tablet, duodenal infusion and sipped solution. Br J Clin Pharmacol 21: 459-462.
27. Lin HC, Sanders SL, Gu YG, Doty IE (1994) Erythromycin accelerates solid emptying at the expense of gastric sieving. Dig Dis Sci 39: 124-128.
28. Marathe PH, Salazar DE, Greene DS, Brennan J, Shukla UA, Barbhaiya RH (1995) Absorption and presystemic metabolism of nefazodone administered at different regions in the gastrointestinal-tract of humans. Pharm Res 12: 1716-1721.
29. Möes AJ (1993) Gastroretentive dosage forms. Crit Rev Ther Drug Carrier Syst 10: 143-195.
30. Mojaverian P (1996) Evaluation of gastrointestinal pH and gastric residence time via the Heidelberg Radiotelemetry Capsule: Pharmaceutical Application. Drug Dev Res 38: 73-85.
31. Naslund E, Gryback P, Backman L, Jacobsson H, Holst JJ, Theodorsson E, Hellstrom PM (1998) Distal small bowel hormones: correlation with fasting antroduodenal motility and gastric emptying. Dig Dis Sci 43: 945-952.
32. Schroeder S, Jetter A, Zaigler M, Weyhenmeyer R, Krambiegel G, Waechter W, Fuhr U (2004) Absorption pattern of trospium chloride along the human gastrointestinal tract assessed using local enteral administration. Int J Clin Pharmacol Ther 42: 543-549.
33. Schulze-Delrieu K, Herman RJ, Shirazi SS, Brown BP (1998) Contractions move contents by changing the configuration of the isolated cat stomach. Am J Physiol Gastrointest Liver Physiol 274: 359-369.
34. Singh BN, Kim KH (2000) Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release 60: 235-259.
35. Staib AH, Loew D, Harder S, Graul EH, Pfab R (1986) Measurement of theophylline absorption from different regions of the gastro-intestinal tract using a remote controlled drug delivery device. Eur J Clin Pharmacol 30: 691-697.
36. Stripp B (1965) Intestinal absorption of riboflavin by man. Acta Pharmacol Toxicol 22: 353-362.
37. Suttmann H, Pietsch E, Vollmer E, Froschle GW (2002) Small bowel obturation ileus related to ingestion of a medical device. 127: 720-722.
38. Vidon N, Palma R, Godbillon J, Franchisseur C, Gosset G, Bernier JJ, Hirtz J (1986) Gastric and intestinal absorption of oxprenolol in humans. J Clin Pharmacol 26: 611-615.
39. Vila JI, Calpena AC, Obach R, Domenech J (1992) Gastric, intestinal and colonic absorption of a series of beta-blockers in the rat. Int J Clin Pharmacol Ther 30: 280-286.